131-I-Sodium Iodide Capsules
ClosedKey facts
- Estimated value
- €150,000
- Deadline
- Expired
- CPV Code
- 33696400-9 — Isotopic reagents
- Procedure
- Open procedure
Original Tender Description
Run Risk Analysis
Identify potential risks, inconsistencies, and red flags across all tender documents. Get a detailed risk report with severity levels and mitigation recommendations.
LoginWin Strategy
Get an AI-powered winning strategy tailored to this tender. Includes win probability score, key opportunities and challenges, recommended bid focus areas, competitive positioning insights, and actionable recommendations to maximize your chances.
LoginCompetitors
Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.
LoginRequirements & Qualifications
26 requirements across 5 categories
Requirements Preview
Sign up to view complete requirements and analysis
Documents
7 documents available with AI summaries
This document outlines the conditions for submitting a compliant tender, detailing requirements for the offer's content, cost structure, technical documentation, and necessary forms and supporting documents.
Bidders must complete and submit this annex, detailing the offered 131-I sodium iodide capsules, including activities, product names, manufacturers, and unit prices.
Bidders must submit a completed tender form detailing the technical specifications, delivery conditions, and unit prices for various activity levels of 131-I sodium iodide capsules, including transport costs.
This document is an application form where the bidder confirms understanding and agreement with the public procurement conditions, comprehensive consideration of the offer's cost, and the offer's validity.
The successful bidder for the tender will be determined 100% based on the offer price, with the lowest price receiving maximum points, and in case of equal offers, preference will be given to bidders with an EEA marketing authorization.
This document is an explanatory ESPD (European Single Procurement Document) outlining the conditions and qualification requirements for the 131-I sodium iodide capsules tender, serving for familiarization only, as the actual ESPD must be submitted electronically.
This document is a draft framework agreement for the sale of radiopharmaceuticals, specifically 131-I-sodium iodide capsules, outlining the terms and obligations between the buyer and seller.
Documents Preview
Sign up to view document summaries and analysis
Tender Quality Score
This tender is generally well-structured and transparent, but it presents some areas for improvement regarding contract duration clarity and data consistency. The specialized nature of the product (radioactive capsules) influences certain aspects of the procurement.
Score Breakdown
Deadlines are reasonable, and the CPV code is appropriate. The vagueness of the procedure type and 'N/A' codes for Type/Procedure is a minor weakness. No disputes or suspensions are detected, and it appears to comply with national and international (WTO/GPA) regulations.
The product description and technical requirements are clear. Evaluation criteria are specified as 100% price, resolving an initial inconsistency. However, the relationship between the estimated value and the maximum value could be more explicitly defined.
Basic information, deadlines, and value are provided. A significant omission is the actual duration of the framework agreement, which is crucial for bidders' planning and understanding of the contract's scope.
Full document access, disclosed value, and reasonable deadlines contribute to fairness. Evaluation criteria are objective, and e-procurement is enabled. Requirements are specific to the product and its regulatory environment, not tailored to a specific company. The 'Max Participants: 1' for a framework agreement is unusual but may be justified by the highly specialized market.
Electronic submission is supported, and a contract start date is known. However, the absence of a clear contract duration significantly impacts the practicality for bidders to plan and assess long-term commitments.
Most key fields are populated. However, there is a clear contradiction between 'Evaluation Criteria: relative_weighting' and '100% based on offer price', even if clarified by a specific document. The discrepancy between estimated and maximum value also lacks full explanation.
The tender does not include specific green, social, or innovation criteria. As a procurement for a specialized medical product, these aspects are often not primary considerations, leading to a neutral score.
Strengths
Concerns
Recommendations
AI Scoring Preview
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
AI Copilot
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required